Livingstone PRH

SGD 0.02 +0.00% +0.00 Updated 18 Nov 2026, 17:16 SGT

Company profile

The business, the people and the ownership behind Livingstone.

Business overview

About the company

Livingstone Health provides specialist healthcare and primary healthcare services. These activities form its principal reportable operating segments.

Annual Report 2026 ↗ Reviewed 2026-10-23 · Source dated 2026-07-13. PDF p. 149

Listed security

Company & listing

Full Company Name
LIVINGSTONE HEALTH HOLDINGS LIMITED
Trading Currency
SGD
Website
www.livingstonehealth.com.sg
Listing
Listed on 8 February 2021 on CATALIST
ISIN Code
SGXE70643320

Board & management

Leadership

MR. TEH WING KWAN

Non-Executive and Non-Independent Chairman

Board of Directors

DR. TAY CHING YIT, WILSON

Executive Director and Chief Executive Officer

Board of Directors; CEO

MR. DAX NG YUNG SERN

Executive Director and Chief Commercial Officer

Board of Directors

MR. FONG HENG BOO

Lead Independent and Non-Executive Director

Board of Directors

MR. CHAN YU MENG

Independent and Non-Executive Director

Board of Directors

Roles listed in Livingstone Health Holdings Limited Annual Report 2026; current appointments are not independently verified.

Holdings

Ownership

Tay Ching Yit, Wilson

Direct 48,466,200 shares (7.69%); deemed 258,373,267 shares (40.97%); total 306,839,467 shares (48.66%)

Substantial shareholdings; % based on 630,592,000 shares

Dax Ng Yung Sern

Direct 10,499,576 shares (1.67%); deemed nil; total 10,499,576 shares (1.67%)

Substantial shareholdings table (director); % based on 630,592,000 shares

Fong Heng Boo

No direct or deemed interest (–)

Substantial shareholdings table (director); % based on 630,592,000 shares

Chan Yu Meng

No direct or deemed interest (–)

Substantial shareholdings table (director); % based on 630,592,000 shares

Livingstone Health Consolidated Pte. Ltd.

Direct 258,373,267 shares (40.97%); deemed nil; total 258,373,267 shares (40.97%)

Substantial Shareholders (Other than Directors); % based on 630,592,000 shares

Chua Meng Hui Sebastian4

Direct 24,183,900 shares (3.84%); deemed 258,373,267 shares (40.97%); total 282,557,167 shares (44.81%)

Substantial Shareholders (Other than Directors); % based on 630,592,000 shares

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 21 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-06-16 · PDF p. 162

Registered holderInterestShares / unitsSource
LIVINGSTONE HEALTH CONSOLIDATED PTE. LTD.Rank 1; 258,373,267 shares; 40.97%PDF p. 1622026-06-16
TAY CHING YIT WILSONRank 2; 48,466,200 shares; 7.69%PDF p. 1622026-06-16
DBS NOMINEES (PRIVATE) LIMITEDRank 3; 32,929,470 shares; 5.22% (nominee)PDF p. 1622026-06-16
CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD.Rank 4; 28,526,134 shares; 4.52%PDF p. 1622026-06-16
CHUA MENG HUI, SEBASTIAN(CAI MINGHUI, SEBASTIAN)Rank 5; 24,183,900 shares; 3.84%PDF p. 1622026-06-16
LIM PANG YEN RACHELRank 6; 23,410,080 shares; 3.71%PDF p. 1622026-06-16
CHUA HSHAN CHERRank 7; 22,364,035 shares; 3.55%PDF p. 1622026-06-16
LEE KAI LUNRank 8; 20,826,963 shares; 3.30%PDF p. 1622026-06-16
LIU HUARank 9; 16,193,400 shares; 2.57%PDF p. 1622026-06-16
PHILLIP SECURITIES PTE LTDRank 10; 13,656,757 shares; 2.17%PDF p. 1622026-06-16
DAX NG YUNG SERN (DAX HUANG YONGSHENG)Rank 11; 10,499,576 shares; 1.67%PDF p. 1622026-06-16
MAYBANK SECURITIES PTE. LTD.Rank 12; 10,236,624 shares; 1.62%PDF p. 1622026-06-16
CHENG KWEE THIAM (ZHONG GUITIAN)Rank 13; 6,307,100 shares; 1.00%PDF p. 1622026-06-16
ICH CAPITAL PTE LTDRank 14; 5,935,560 shares; 0.94%PDF p. 1622026-06-16
KGI SECURITIES (SINGAPORE) PTE. LTDRank 15; 5,476,380 shares; 0.87%PDF p. 1622026-06-16
OCBC SECURITIES PRIVATE LIMITEDRank 16; 5,302,786 shares; 0.84%PDF p. 1622026-06-16
FOONG CHING CHING ANGELARank 17; 4,877,746 shares; 0.77%PDF p. 1622026-06-16
TAN KIM YEOWRank 18; 4,655,600 shares; 0.74%PDF p. 1622026-06-16
TAN MARK TERENCERank 19; 3,800,000 shares; 0.60%PDF p. 1622026-06-16
LEE WEE NGAMRank 20; 3,600,000 shares; 0.57%PDF p. 1622026-06-16
TOTAL549,621,578 shares; 87.16%PDF p. 1622026-06-16

Group structure

Main operating subsidiaries

CompanyMarketOwnership interest
Livingstone Health Ltd. (“LHL”)(1)Held directly by the CompanyPDF p. 130 Singapore
Livingstone Health Ltd. (“LHL”)(1)Held directly by the Company; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Precision Medical Services Pte. Ltd.(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Precision Medical Services Pte. Ltd.(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Livingstone Endocrine Pte. Ltd.(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Livingstone Endocrine Pte. Ltd.(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
The Bone and Joint Centre Pte. Ltd.(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
The Bone and Joint Centre Pte. Ltd.(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Al Tirah Anaesthesia Services Pte. Ltd.(1) (“ATAS”)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Al Tirah Anaesthesia Services Pte. Ltd.(1) (“ATAS”)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 51; 2025: 51
RL Aesthetics Pte. Ltd. (“RL”)(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
RL Aesthetics Pte. Ltd. (“RL”)(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Apicare Pain Specialist Pte. Ltd. (“APS”)(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Apicare Pain Specialist Pte. Ltd. (“APS”)(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Sebastian Chua MH Pte. Ltd.(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Sebastian Chua MH Pte. Ltd.(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Cove Sports & Reconstruction Pte. Ltd.(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Cove Sports & Reconstruction Pte. Ltd.(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
LSH SurgiSuites Pte. Ltd.(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
LSH SurgiSuites Pte. Ltd.(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Livingstone Health International Pte. Ltd. (“LHI”)(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Livingstone Health International Pte. Ltd. (“LHI”)(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Phoenix Medical Group Pte. Ltd. (“PMG”)(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Phoenix Medical Group Pte. Ltd. (“PMG”)(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Livingstone Gastroenterology & Liver Pte. Ltd.(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Livingstone Gastroenterology & Liver Pte. Ltd.(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Prism Partnerships (SG) Pte. Ltd.(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Prism Partnerships (SG) Pte. Ltd.(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Quantum Orthopaedics Pte. Ltd. (“QO”)(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Quantum Orthopaedics Pte. Ltd. (“QO”)(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 51; 2025: 51
Allied Health Partners Pte. Ltd.(1) (fka Virtuemed Pte. Ltd. (“VM”))Held through Livingstone Health Ltd.PDF p. 130 Singapore
Allied Health Partners Pte. Ltd.(1) (fka Virtuemed Pte. Ltd. (“VM”))Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: –; 2025: 51
Cove Dermatology Pte. Ltd.(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Cove Dermatology Pte. Ltd.(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 100; 2025: 100
Phoenix Healthcare Solutions Pte. Ltd. (“PHS”)(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Phoenix Healthcare Solutions Pte. Ltd. (“PHS”)(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 51; 2025: 51
Atlas Podiatry Pte. Ltd.(1)Held through Livingstone Health Ltd.PDF p. 130 Singapore
Atlas Podiatry Pte. Ltd.(1)Held through Livingstone Health Ltd.; effective equity held by the Group; 2026 vs 2025PDF p. 130 2026: 85; 2025: 85
Venture Investment Pte. Ltd. (“VIPL”)(2)Held through LHIPDF p. 131 Singapore
Venture Investment Pte. Ltd. (“VIPL”)(2)Held through LHI; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: –; 2025: 100
Atlas Physiotherapy Pte. Ltd.(3)Held through VIPLPDF p. 131 Singapore
Atlas Physiotherapy Pte. Ltd.(3)Held through VIPL; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: –; 2025: 100
Cove Aesthetics T Pagar Pte. Ltd.(1)Held through RLPDF p. 131 Singapore
Cove Aesthetics T Pagar Pte. Ltd.(1)Held through RL; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: 100; 2025: 100
PMG HV Pte. Ltd.(1)Held through PMGPDF p. 131 Singapore
PMG HV Pte. Ltd.(1)Held through PMG; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: 100; 2025: 100
PMG PL Pte. Ltd.(1)Held through PMGPDF p. 131 Singapore
PMG PL Pte. Ltd.(1)Held through PMG; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: 100; 2025: 100
PMG RH Pte Ltd. (fka PMG Int 2 Pte. Ltd.)(1)Held through PMGPDF p. 131 Singapore
PMG RH Pte Ltd. (fka PMG Int 2 Pte. Ltd.)(1)Held through PMG; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: 100; 2025: –
Wellington Pte. Ltd.(4)Held through PMGPDF p. 131 Singapore
Wellington Pte. Ltd.(4)Held through PMG; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: 100; 2025: –
PMG NV Pte. Ltd. (fka PMG CACTIII Pte. Ltd.) (1)Held through PHSPDF p. 131 Singapore
PMG NV Pte. Ltd. (fka PMG CACTIII Pte. Ltd.) (1)Held through PHS; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: 35.7; 2025: 35.7
Ardennes Healthcare Pte. Ltd. (1)Held through PHSPDF p. 131 Singapore
Ardennes Healthcare Pte. Ltd. (1)Held through PHS; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: 51; 2025: 51
PMG TH Pte. Ltd. (1)Held through PHSPDF p. 131 Singapore
PMG TH Pte. Ltd. (1)Held through PHS; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: 51; 2025: 51
Fidelity Neuroscience Pte. Ltd. (“FNS”)(1)Held through APSPDF p. 131 Singapore
Fidelity Neuroscience Pte. Ltd. (“FNS”)(1)Held through APS; effective equity held by the Group; 2026 vs 2025PDF p. 131 2026: 51; 2025: 51

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
DR. CHUA HSHAN CHER DEPUTY CHIEF EXECUTIVE OFFICER; HEAD OF FAMILY MEDICINE PDF p. 9
MR. WONG QINGYUAN CHIEF FINANCIAL OFFICER PDF p. 9
DR. RACHEL LIM HEAD OF AESTHETICS AND WELLNESS PDF p. 10
DR. SEBASTIAN CHUA HEAD OF ANAESTHESIOLOGY AND PAIN MANAGEMENT PDF p. 10

Extracted from Livingstone Health Holdings Limited Annual Report 2026 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
Number of Issued Shares 630,592,000 shares As at 16 June 2026 · As at 2026-06-16 PDF p. 162
Class of Shares Ordinary As at 16 June 2026 · As at 2026-06-16 PDF p. 162
Voting Rights One vote per ordinary share As at 16 June 2026 · As at 2026-06-16 PDF p. 162

Treasury shares

ItemValuePeriod / scopeSource
Number of Treasury Shares Nil As at 16 June 2026 · As at 2026-06-16 PDF p. 162
Number of Subsidiary Holdings Nil As at 16 June 2026 · As at 2026-06-16 PDF p. 162

Shareholding distribution

ItemValuePeriod / scopeSource
TOTAL 4,829 shareholders Total number of shareholders, as at 16 June 2026 · As at 2026-06-16 PDF p. 162
1 – 99 1,788 holders; 37.02% of holders; 52,987 shares; 0.01% of shares As at 16 June 2026 · As at 2026-06-16 PDF p. 162
100 – 1,000 1,818 holders; 37.65% of holders; 741,027 shares; 0.12% of shares As at 16 June 2026 · As at 2026-06-16 PDF p. 162
1,001 – 10,000 835 holders; 17.29% of holders; 2,724,261 shares; 0.43% of shares As at 16 June 2026 · As at 2026-06-16 PDF p. 162
10,001 – 1,000,000 348 holders; 7.21% of holders; 41,565,273 shares; 6.59% of shares As at 16 June 2026 · As at 2026-06-16 PDF p. 162
1,000,001 AND ABOVE 40 holders; 0.83% of holders; 585,508,452 shares; 92.85% of shares As at 16 June 2026 · As at 2026-06-16 PDF p. 162

Free float

ItemValuePeriod / scopeSource
PERCENTAGE OF SHAREHOLDING IN PUBLIC HANDS 29.99% of the Company issued and paid-up capital is held in the hands of public. As at 16 June 2026 PDF p. 163
PERCENTAGE OF SHAREHOLDING IN PUBLIC HANDS Accordingly, the Company had complied with Rule 723 of the Listing Manual Section B: Rules of Catalist of the Singapore Exchange Securities Trading Limited. PDF p. 163

Extracted from Livingstone Health Holdings Limited Annual Report 2026 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Rental paid (251,093) S$ Group; Company related to a director of the Company; 2026 PDF p. 151
Sales of services to 19,510 S$ Group; Company related to a director of the Company; 2026 PDF p. 151
Administrative income 76,000 S$ With an associate; 2026 PDF p. 151
Sales of services to 100,616 S$ With an associate; 2026 PDF p. 151
Compensation of directors and key management personnel 8,400,060 S$ Group; total of short-term and post-employment benefits; 2026 PDF p. 151

Contingent liabilities

ItemValuePeriod / scopeSource
Contingent liabilities the Company and certain subsidiaries have given a corporate guarantee to a bank for bank borrowings, Loan 1 to Loan 6 in respect to the banking facilities granted to a subsidiary (Note 22) Company and certain subsidiaries; as at 31 March 2026 · As at 2026-03-31 PDF p. 149

Director remuneration

ItemValuePeriod / scopeSource
Dr Tay Ching Yit, Wilson 1,267 S$'000 Group; total remuneration FY2026 PDF p. 64
Mr Dax Ng Yung Sern 292 S$'000 Group; total remuneration FY2026 PDF p. 64
Mr Teh Wing Kwan 42 S$'000 Group; total remuneration FY2026 PDF p. 64
Mr Fong Heng Boo 42 S$'000 Group; total remuneration FY2026 PDF p. 64
Mr Chan Yu Meng 39 S$'000 Group; total remuneration FY2026 PDF p. 64
Directors' fees recommended S$124,000 Proposed for financial year ending 31 March 2027 PDF p. 64
Aggregate compensation of four key management personnel approximately S$1,842,000 Four key management personnel, FY2026 PDF p. 65

Employees

ItemValuePeriod / scopeSource
Total No. of Employees 91 employees Group; as at 31 March 2026 · As at 2026-03-31 PDF p. 34

Outlook

ItemValuePeriod / scopeSource
Looking Ahead the Group remains cautious of the business outlook as the operating environment continues to be challenging with rising business costs Joint statement by Chairman and CEO PDF p. 5

Extracted from Livingstone Health Holdings Limited Annual Report 2026 and checked against the cited pages; see the original report for full context.

Source: Livingstone Health Holdings Limited Annual Report 2026 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
08 Apr 2004
Email
[email protected]
Telephone
+65 6592 4855
Fax
+65 6592 4859
Registered Office
Blk 217 Henderson Road
#01-09
Singapore 159555
Secretary
Gn Jong Yuh Gwendolyn
Registrar / Transfer Agent
BOARDROOM CORPORATE & ADVISORY SERVICES PTE. LTD.
Registrar Address
1 Harbourfront Avenue, Keppel Bay Tower, #14-07, Singapore 098632
Auditors
FORVIS MAZARS LLP
Other Stock Exchange Listings
*SINGAPORE EXCHANGE (CATALIST)
Country
SINGAPORE
Security Type
stocks